Emerging Research

Is There a Way to Know When My JAK2 Mutation Occurred?

Ropeginterferon Offers New Option for Treatment of MPNs

Ruth Fein, Jeanne Palmer, MD

Myeloproliferative Neoplasms in Children and Young Adults

Esther Schorr, Nicole Kucine, MD, Portia Pliam

Navitoclax in Combination for Myelofibrosis Patients

Srdan Verstovsek, MD, PhD, Andrew Schorr

The Road to Curing MPNs

Ruth Fein, Ross L. Levine, MD

ASH 2020 MPN Daily Wrap-Up: New Research and Early Detection

Andrew Schorr, Esther Schorr, Naveen Pemmaraju, MD, Michael Mauro, MD

MPN Ask Me Anything: New Medications, Clinical Trials and More

Esther Schorr, Ruben Mesa, MD

New Phase 3 Clinical Trial for Myelofibrosis Patients

Andrew Schorr, John Mascarenhas, MD

The Leading Edge of Myeloproliferative Neoplasms Treatment

Ruth Fein, Srdan Verstovsek, MD, PhD, Andrew Schorr

New Clinical Trial for Myelofibrosis Patients with JAK2 Mutation

Andrew Schorr, Srinivas K. Tantravahi, MBBS, MRCP

Hereditary Trends in MPNs

Angela Fleischman, MD, PhD, Esther Schorr

MPN Experts Discuss Clinical Trials and Transplants

Jeanne Palmer, MD, Naveen Pemmaraju, MD, Phil Arner, Andrew Schorr

Cancer News Sent to You

Get e-Newsletters with the most current information about your health condition sent to your email!

Sign Up